BioSpace News Archive

APstem Therapeutics, Inc., a private biopharmaceutical company developing breakthrough stem cell therapies, today announced the completion of an INitial Targeted Engagement for Regulatory Advice on CBER ProducTs (INTERACT) meeting with the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) Office of Tissues and Advanced Therapies (OTAT)

The American Heart Association’s 2021 Paul “Bear” Bryant Heart of a Champion Award honors a college football coach for outstanding accomplishments both on and off the field

Scholar Rock Holding Corporation, a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, announced the pricing of an underwritten public offering of 2,948,718 shares of its common stock at a public offering price of $39.00 per share.

Synthetic biology market has evolved on the back of surging industry interest worldwide on the profound capabilities it is said to possess, mainly by virtue of redesigning biological components and systems.

According to the report, the global positron emission tomography scanners market was valued at US$ 915.5 Mn in 2019 and is projected to expand at a CAGR of 3% from 2020 to 2030.

The demand within the global healthcare e-commerce market is growing on back of continuous advancements in the e-commerce industry and online sales of medication.

The surging cases of neurological disorders and traumatic brain injuries are the key factors boosting the global external ventricular drain market growth.

Loss of neutrophils causes disruption of immune defense mechanisms and increases the likelihood for infections. Neutropenia is frequently associated with cancer chemotherapy and developed by majority of cancer patients during chemotherapy.

Anti-infective agents are drugs used for the purpose of killing and/or suppressing the infection causing organisms from invading the host by means of its replication or releasing variety of toxins into the host.

At a virtual ceremony today, Samsung Biologics (KRX: 207940.KS) announced the grand opening of its first US CDO R&D Center in San Francisco, bringing its contract development services closer to global client